As we approach 2025, the technological landscape continues to evolve at an unprecedented pace. The rapid development of emerging technologies is poised to revolutionize industries ranging from transportation to healthcare over the next decade. Innovations like causal AI and next-generation large language models (LLMs) are set to transform traditional methods, enabling businesses across sectors...

The U.S. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market is set for robust growth over the next decade. Valued at USD 214.00 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.50% from 2025 to 2034, reaching an estimated USD 440.23 million by the end of the forecast period. This growth is largely fueled by...